Continuous Glucose Monitoring for Diabetes

IC
Overseen ByInnovative Clinical and Outcomes Research (iCOR)
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of the Pacific
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a clinical trial looking at differences in continuous glucose monitor (CGM) glucose readings between the left and right arms in adults with type 1 or type 2 diabetes. The study will enroll 60 participants who will wear a CGM sensor on both arms for 14 days.

Are You a Good Fit for This Trial?

This trial is for adults with type 1 or type 2 diabetes who are able to wear a continuous glucose monitor on both arms for two weeks. People with conditions that prevent safe use of the device may not be eligible.

Inclusion Criteria

A1c <7% within the past 6 months
Have active health insurance throughout the duration of the study
Willing to refrain from consuming or using commercial products containing ascorbic acid (vitamin C) or salicylic acid, and certain skincare products for the duration of the study due to their known potential to interfere with CGM readings (exposure via food is allowed)
See 6 more

Exclusion Criteria

History of allergic reactions or hypersensitivity to adhesives
I am currently taking hydroxyurea.
Implanted medical devices such as pacemaker or insulin pump
See 11 more

What Are the Treatments Tested in This Trial?

Trial Overview

The study tests if there are differences in blood sugar readings from CGM sensors worn on the left versus right arm using the FreeStyle Libre 3 Plus system. Each participant wears sensors on both arms for 14 days.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Left and Right Arm CGM WearExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of the Pacific

Lead Sponsor

Trials
16
Recruited
1,000+